Neuraxis reports second quarter 2023 financial results

Carmel, ind., sept. 21, 2023 (globe newswire) -- neuraxis, inc. (nyse american: nrxs) (“neuraxis” or the “company”), a medical technology company commercializing neuromodulation therapies that address chronic and debilitating conditions in children and adults, today reported financial results for the second quarter ended june 30, 2023.
NRXS Ratings Summary
NRXS Quant Ranking